8-K

Company

Barinthus Biotherapeutics plc.

Filed

March 13, 2026

Period of Report

March 13, 2026

Accession Number

0001828185-26-000011

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →